Divalproex Sodium Tablet, Delayed Release
NDC 60687-857
Product Information
Divalproex Sodium is a ANDA-approved product labeled by American Health Packaging. This medication is typically used as a anti-epileptic agent [epc]. It is supplied as a orange tablet, delayed release for oral administration. This product entry covers the primary NDC 60687-857 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
UL;125 Code Structure Chart
Product Details
What is NDC 60687-857?
What are the uses of this product?
What are Active Ingredients of this product?
- DIVALPROEX SODIUM 125 mg/1 - A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DIVALPROEX SODIUM (UNII: 644VL95AO6)
- VALPROIC ACID (UNII: 614OI1Z5WI) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MICROCRYSTALLINE CELLULOSE 112 (UNII: X7XJ6RM9Q2)
- POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)
- STARCH, CORN (UNII: O8232NY3SJ)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- TALC (UNII: 7SEV7J4R1U)
- VANILLIN (UNII: CHI530446X)
- HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- POLYETHYLENE GLYCOL 3000 (UNII: SA1B764746)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIACETIN (UNII: XHX3C3X673)
- ALCOHOL (UNII: 3K9958V90M)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SHELLAC (UNII: 46N107B71O)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- ISOPROPYL ALCOHOL (UNII: ND2M416302)
- BUTYL ALCOHOL (UNII: 8PJ61P6TS3)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
- METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER (UNII: NX76LV5T8J)
- SODIUM BICARBONATE (UNII: 8MDF5V39QO)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1099625 - divalproex sodium 125 MG Delayed Release Oral Tablet
- RxCUI: 1099678 - divalproex sodium 250 MG Delayed Release Oral Tablet
- RxCUI: 1099870 - divalproex sodium 500 MG Delayed Release Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.